Clinical Trial: A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus

U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07339332) titled 'A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus' on Nov. 18, 2025.

Brief Summary: This study is a single arm, open, exploratory dose escalation clinical study to evaluate the safety, efficacy, and cellular metabolic dynamics of ct1195e cells in patients with SLE.

Study Start Date: Jan. 16

Study Type: INTERVENTIONAL

Condition: Systemic Lupus Erythematosus (SLE)

Intervention: OTHER: CAR-T Therapy

CT1195E cells infusion

Recruitment Status: RECRUITING

Sponsor: Union Hospital, Tongji Medical Colle...